PipelinePharma Logo

Generics 1

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Exenatide manufacturers

1 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

1 products found

exenatide

Injection 5 mcg, 10 mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21424

Established in 1987, this Manufacturer is a fully integrated biopharmaceutical entity specializing in human insulin, analogue insulin, and GLP-1 agents, offering both drug substances and formulations. As a CTD dossier owner and manufacturer, it provides comprehensive services from proof of concept to commercial scale, including yield optimization and contract manufacturing in vials, ampoules, cartridges, and disposable pens. Operating two manufacturing facilities—one in Taloja, Navi Mumbai, certified with WHO-GMP compliance to PIC standards, and another in Pune adhering to European Medicines Evaluation Agency (EMEA) and US FDA standards—the Manufacturer ensures high-quality production. With a workforce of approximately 500 employees, its products are accredited in over 30 countries and regions worldwide. As a GMP manufacturer, it maintains stringent quality standards across all operations. Committed to global health, this CTD dossier owner and manufacturer continues to expand its presence in regulated markets

Manufacturer usually replies in 13 days

Want to see all 1 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Exenatide is a medication that is used to treat type 2 diabetes. The supplier of exenatide markets it in the form of fast-release as well as extended-release injectable solution preparation kits as well as injectable solutions. The drug was first approved for medical use in 2005 and has since become registered and marketed in over 80 countries worldwide. Exenatide’s manufacturer is Amylin Pharmaceuticals, whereas the commercialization and distribution rights belong to Astra Zeneca (i.e. it is the sole exenatide supplier globally). Given that the supplier’s patent for exenatide is still valid, other manufacturers and vendors have yet to introduce generic or trade name formulations of the drug. The retail prices per 4 injectable solution kits with 2mg powder of exenatide and solvent for an extended-release injectable solution costs approximately 90,00 EUR to 120,00 EUR. Pharmaceutical specialists are welcome to browse through offers of exenatide injectable solution kits for sale from exenatide suppliers and distributors on our pharmaceutical marketplace, or else seek out further useful medical information about the medication online at the official Byetta website.

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible